← Back to Search

Microfluidics Device

ZyMot Multi Sperm Separation Device (850 ul) for Assisted Reproductive Technology

N/A
Waitlist Available
Led By Rani Fritz, DO, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up culture day 5 or 6
Awards & highlights

Summary

This trial will compare the success of two different methods of separating sperm for ICSI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~culture day 5 or 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and culture day 5 or 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Good Quality Blastocyst Formation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ZyMot SeparationExperimental Treatment1 Intervention
Treatment
Group II: Density Gradient CentrifugationActive Control1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ZyMot Multi Sperm Separation Device (850 ul)
2021
N/A
~110

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,379 Previous Clinical Trials
848,010 Total Patients Enrolled
Rani Fritz, DO, PhDPrincipal InvestigatorNYU Langone Health
~26 spots leftby Jul 2025